122 related articles for article (PubMed ID: 11838959)
1. Salmonella-mediated mucosal cell-mediated immunity.
Lillard JW; Boyaka PN; Singh S; McGhee JR
Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1115-20. PubMed ID: 11838959
[TBL] [Abstract][Full Text] [Related]
2. Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.
Han YW; Kim SB; Rahman M; Uyangaa E; Lee BM; Kim JH; Park KI; Hong JT; Han SB; Eo SK
Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):335-45. PubMed ID: 21543119
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella.
VanCott JL; Staats HF; Pascual DW; Roberts M; Chatfield SN; Yamamoto M; Coste M; Carter PB; Kiyono H; McGhee JR
J Immunol; 1996 Feb; 156(4):1504-14. PubMed ID: 8568254
[TBL] [Abstract][Full Text] [Related]
4. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
5. Sensitized liposomes as an antigen delivery system for the stimulation of mucosal immunity.
Velez CN; Tonkonogy SL; Lichtman SN; Cho MJ
J Drug Target; 1997; 5(1):15-24. PubMed ID: 9524310
[TBL] [Abstract][Full Text] [Related]
6. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.
Alignani D; Maletto B; Liscovsky M; Rópolo A; Morón G; Pistoresi-Palencia MC
J Leukoc Biol; 2005 Jun; 77(6):898-905. PubMed ID: 15758079
[TBL] [Abstract][Full Text] [Related]
7. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
8. Entry route of Salmonella typhimurium directs the type of induced immune response.
Martinoli C; Chiavelli A; Rescigno M
Immunity; 2007 Dec; 27(6):975-84. PubMed ID: 18083577
[TBL] [Abstract][Full Text] [Related]
9. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 5 is not essential for the promotion of secretory immunoglobulin A antibody responses to flagellated bacteria.
Hashizume-Takizawa T; Yamamoto M
Microbiol Immunol; 2015 Dec; 59(12):716-23. PubMed ID: 26564803
[TBL] [Abstract][Full Text] [Related]
11. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
12. Characterization of immune responses following intranasal immunization with the Mycobacterium bovis CFP-10 protein expressed by attenuated Salmonella typhimurium.
Zhang H; Wen K; Shen J; Geng S; Huang J; Pan Z; Jiao X
Scand J Immunol; 2010 Oct; 72(4):277-83. PubMed ID: 20883312
[TBL] [Abstract][Full Text] [Related]
13. Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses.
Bumann D
Infect Immun; 2001 Dec; 69(12):7493-500. PubMed ID: 11705925
[TBL] [Abstract][Full Text] [Related]
14. New perspectives in vaccine development: mucosal immunity to infections.
McGhee JR; Kiyono H
Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
[TBL] [Abstract][Full Text] [Related]
15. Avirulant Salmonella typhimurium strains prevent food allergy in mice.
Eigenmann PA; Asigbetse KE; Frossard CP
Clin Exp Immunol; 2008 Mar; 151(3):546-53. PubMed ID: 18190606
[TBL] [Abstract][Full Text] [Related]
16. Essential role of Peyer's patches in the development of Helicobacter-induced gastritis.
Kiriya K; Watanabe N; Nishio A; Okazaki K; Kido M; Saga K; Tanaka J; Akamatsu T; Ohashi S; Asada M; Fukui T; Chiba T
Int Immunol; 2007 Apr; 19(4):435-46. PubMed ID: 17314082
[TBL] [Abstract][Full Text] [Related]
17. Chimeric flagellin expressed by Salmonella typhimurium induces an ESAT-6-specific Th1-type immune response and CTL effects following intranasal immunization.
Zhang H; Liu L; Wen K; Huang J; Geng S; Shen J; Pan Z; Jiao X
Cell Mol Immunol; 2011 Nov; 8(6):496-501. PubMed ID: 21841816
[TBL] [Abstract][Full Text] [Related]
18. Mucosal vaccination using claudin-4-targeting.
Kakutani H; Kondoh M; Fukasaka M; Suzuki H; Hamakubo T; Yagi K
Biomaterials; 2010 Jul; 31(20):5463-71. PubMed ID: 20398936
[TBL] [Abstract][Full Text] [Related]
19. The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin.
Suzuki H; Kakutani H; Kondoh M; Watari A; Yagi K
Pharmazie; 2010 Oct; 65(10):766-9. PubMed ID: 21105580
[TBL] [Abstract][Full Text] [Related]
20. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
